Profiel
Dr. Harry Kopelman, MD, is Scientific Advisor at Easton Capital Investment Group.
Dr. Kopelman is a graduate of the Georgetown University School of Medicine, Washington, D.C.
(1980).
He completed his internship/residency at North Carolina Memorial Hospital/University of North Carolina, Chapel Hill (1983).
His fellowship in Cardiovascular Disease and Cardiac Electrophysiology was at the Vanderbilt University School of Medicine in Nashville, TN (1985).
Eerdere bekende functies van Harry Kopelman
| Bedrijven | Functie | Einde |
|---|---|---|
Arterain Medical, Inc.
Arterain Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to treat large vessel acute ischemic strokes | Directeur/Bestuurslid | - |
Easton Capital Investment Group
Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor. | Corporate Officer/Principal | - |
Opleiding van Harry Kopelman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Arterain Medical, Inc.
Arterain Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to treat large vessel acute ischemic strokes | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Easton Capital Investment Group
Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor. | Finance |
















